+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Inflammatory Disease Marker Tests - Medical Devices Pipeline Assessment, 2020

  • ID: 5212229
  • Report
  • November 2020
  • Region: Global
  • 135 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abcodia Ltd
  • BioSIMS
  • ELITechGroup Inc
  • LifeAssays AB
  • Quidel Corp
  • University Health Network
  • MORE
Summary

The publisher's Medical Devices sector report, “Inflammatory Disease Marker Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Inflammatory Disease Marker Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Inflammatory Disease Markers are antigen/antibodies that detect specific antigen/antibodies produced by bone, cartilage or any other inflammatory disease activity. This segment includes sub segment analyzer based tests and latex agglutination based tests.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Inflammatory Disease Marker Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inflammatory Disease Marker Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inflammatory Disease Marker Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abcodia Ltd
  • BioSIMS
  • ELITechGroup Inc
  • LifeAssays AB
  • Quidel Corp
  • University Health Network
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Inflammatory Disease Marker Tests Overview

3 Products under Development
3.1 Inflammatory Disease Markers - Pipeline Products by Stage of Development
3.2 Inflammatory Disease Markers - Pipeline Products by Segment
3.3 Inflammatory Disease Markers - Pipeline Products by Territory
3.4 Inflammatory Disease Markers - Pipeline Products by Regulatory Path
3.5 Inflammatory Disease Markers - Pipeline Products by Estimated Approval Date

4 Inflammatory Disease Markers - Pipeline Products under Development by Companies
4.1 Inflammatory Disease Markers Companies - Pipeline Products by Stage of Development
4.2 Inflammatory Disease Markers - Pipeline Products by Stage of Development

5 Inflammatory Disease Markers Companies and Product Overview

6 Inflammatory Disease Markers- Recent Developments

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Inflammatory Disease Markers - Pipeline Products by Stage of Development
Table 2: Inflammatory Disease Markers - Pipeline Products by Segment
Table 3: Inflammatory Disease Markers - Pipeline Products by Territory
Table 4: Inflammatory Disease Markers - Pipeline Products by Regulatory Path
Table 5: Inflammatory Disease Markers - Pipeline Products by Estimated Approval Date
Table 6: Inflammatory Disease Markers Companies - Pipeline Products by Stage of Development
Table 7: Inflammatory Disease Markers - Pipeline Products by Stage of Development
Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Molecular Biomarker - Rheumatoid Arthritis - Product Status
Table 10: Molecular Biomarker - Rheumatoid Arthritis - Product Description
Table 11: Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Hemo One - hs - CRP Assay - Product Status
Table 13: Hemo One - hs - CRP Assay - Product Description
Table 14: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Diagnostic Kit - Rheumatoid Arthritis - Product Status
Table 16: Diagnostic Kit - Rheumatoid Arthritis - Product Description
Table 17: AnaMar AB Pipeline Products & Ongoing Clinical Trials Overview
Table 18: NeoSix Biomarker Assay - Product Status
Table 19: NeoSix Biomarker Assay - Product Description
Table 20: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Diagnostic Test - Rheumatoid Arthritis - Product Status
Table 22: Diagnostic Test - Rheumatoid Arthritis - Product Description
Table 23: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Multiplexed Detection - CRP - Product Status
Table 25: Multiplexed Detection - CRP - Product Description
Table 26: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: AU480 Clinical System - anti-CCP Assay - Product Status
Table 28: AU480 Clinical System - anti-CCP Assay - Product Description
Table 29: AU5810 Clinical System - anti-CCP Assay - Product Status
Table 30: AU5810 Clinical System - anti-CCP Assay - Product Description
Table 31: AU5820 Clinical System - anti-CCP Assay - Product Status
Table 32: AU5820 Clinical System - anti-CCP Assay - Product Description
Table 33: AU5830 Clinical System - anti-CCP Assay - Product Status
Table 34: AU5830 Clinical System - anti-CCP Assay - Product Description
Table 35: AU5840 Clinical System - anti-CCP Assay - Product Status
Table 36: AU5840 Clinical System - anti-CCP Assay - Product Description
Table 37: AU680 Clinical System - anti-CCP Assay - Product Status
Table 38: AU680 Clinical System - anti-CCP Assay - Product Description
Table 39: Multisystem Inflammatory Syndrome Diagnostic Test - Product Status
Table 40: Multisystem Inflammatory Syndrome Diagnostic Test - Product Description
Table 41: UniCel DxC 600 - anti-CCP Assay - Product Status
Table 42: UniCel DxC 600 - anti-CCP Assay - Product Description
Table 43: UniCel DxC 600i Synchron Access - anti-CCP Assay - Product Status
Table 44: UniCel DxC 600i Synchron Access - anti-CCP Assay - Product Description
Table 45: UniCel DxC 680i Synchron Access Clinical System - anti-CCP Assay - Product Status
Table 46: UniCel DxC 680i Synchron Access Clinical System - anti-CCP Assay - Product Description
Table 47: UniCel DxC 800 - anti-CCP Assay - Product Status
Table 48: UniCel DxC 800 - anti-CCP Assay - Product Description
Table 49: UniCel DxC 860i Synchron Access Clinical System - anti-CCP Assay - Product Status
Table 50: UniCel DxC 860i Synchron Access Clinical System - anti-CCP Assay - Product Description
Table 51: UniCel DxC 880i Synchron Access Clinical System - anti-CCP Assay - Product Status
Table 52: UniCel DxC 880i Synchron Access Clinical System - anti-CCP Assay - Product Description
Table 53: BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Inmunobiogram - Arthritis - Product Status

List of Figures
Figure 1: Inflammatory Disease Markers - Pipeline Products by Stage of Development
Figure 2: Inflammatory Disease Markers - Pipeline Products by Segment
Figure 3: Inflammatory Disease Markers - Pipeline Products by Territory
Figure 4: Inflammatory Disease Markers - Pipeline Products by Regulatory Path
Figure 5: Inflammatory Disease Markers - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
3 of 3
  • Abcodia Ltd
  • Adaltis Srl
  • Albert Ludwigs University of Freiburg
  • AnaMar AB
  • Arizona State University
  • AXO Science SAS
  • Beckman Coulter Inc
  • BIOHOPE Scientific SL
  • BiomX Inc
  • BioSIMS
  • Boditech Med Inc
  • CD Diagnostics Inc
  • CDI Laboratories Inc
  • Chronix Biomedical Inc
  • Cincinnati Children's Hospital Medical Center
  • Consejo Superior de Investigaciones Cientificas
  • Crescendo Bioscience Inc
  • DSX Therapeutics LLC
  • DxTerity Diagnostics Inc
  • EKF Diagnostics Holdings Plc
  • ELITechGroup Inc
  • Firalis SAS
  • French National Institute of Health and Medical Research
  • Genalyte Inc
  • Ghent University
  • Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH)
  • Ignyta Inc
  • Johns Hopkins University
  • KineMed Inc
  • Leadgene Biomedical Inc
  • LifeAssays AB
  • Medica Corp
  • Merck Millipore Corp
  • Morehouse School of Medicine
  • Myriad Genetics Inc
  • Neoteryx LLC
  • Ortho-Clinical Diagnostics Inc
  • Phagolum Ltd.
  • Proplex Technologies Llc
  • Protagen AG
  • Queen Mary University of London
  • Quidel Corp
  • Roche Diagnostics Corp
  • Selventa Inc
  • Siemens Healthcare Diagnostics Inc
  • SomaLogic Inc
  • SpinChip Diagnostics AS
  • SQI Diagnostics Inc
  • StageZero Life Sciences Ltd
  • Svar Life Science AB
  • The University of Manchester
  • The Walter and Eliza Hall Institute of Medical Research
  • Thermo Fisher Scientific Inc
  • Toscana Biomarkers Srl
  • University Health Network
  • University of Aberdeen
  • University of Auckland
  • University of California
  • University of California Los Angeles
  • University of Gottingen
  • University of Oxford
  • University of Rochester
  • University of Warwick
  • University Rovira i Virgili
Note: Product cover images may vary from those shown
Adroll
adroll